LY3972406
/ Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
June 27, 2025
A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis
(clinicaltrials.gov)
- P2 | N=33 | Completed | Sponsor: Eli Lilly and Company | Active, not recruiting ➔ Completed | N=75 ➔ 33
Enrollment change • Trial completion • Dermatology • Immunology • Psoriasis
March 05, 2025
A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis
(clinicaltrials.gov)
- P2 | N=75 | Active, not recruiting | Sponsor: Eli Lilly and Company | Recruiting ➔ Active, not recruiting
Enrollment closed • Dermatology • Immunology • Psoriasis
January 05, 2024
A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis
(clinicaltrials.gov)
- P2 | N=75 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting
Enrollment open • Dermatology • Immunology • Psoriasis
December 20, 2023
A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis
(clinicaltrials.gov)
- P2 | N=75 | Not yet recruiting | Sponsor: Eli Lilly and Company
New P2 trial • Dermatology • Immunology • Psoriasis
1 to 4
Of
4
Go to page
1